When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 16 Mar 2025
Last updated: 23 Jan 2019

Summary

Your Organisational Guidance

ebpracticenet urges you to prioritise the following organisational guidance:

Prévention de l’InfluenzaPublished by: Groupe de travail Développement de recommandations de première ligneLast published: 2018Preventie van influenzaPublished by: Werkgroep Ontwikkeling Richtlijnen Eerste Lijn (Worel)Last published: 2018

Definition

History and exam

Key diagnostic factors

  • qış mövsümü
  • hazırkı qrip alovlanması
  • peyvənd olunmamışlar
  • hərarət və öskürək
Full details

Other diagnostic factors

  • boğaz ağrısı
  • boyun limfadenopatiyası
  • təngnəfəslik
Full details

Risk factors

  • 65 yaş və yuxarı
  • 6-59 aylıq uşaqlar
  • xroniki ürək-damar və ya respirator xəstəliklər
  • xroniki böyrək xəstəliyi
  • şəkərli diabet
  • hemoqlobinopatiya
  • immunodefisit
  • hamiləlik
  • yüksək risk qrupundan olanlara qulluq edənlər və onların ailə üzvləri
  • səhiyyə işçiləri
Full details

Diagnostic investigations

1st investigations to order

  • kliniki diaqnoz
Full details

Investigations to consider

  • virus kulturası:
  • düz immunoflüoressent anticisim boyanması
  • əks transkripsiya-polimeraz zəncirvari reaksiya
  • seroloji müayinə
  • immunoferment analiz (İFA)
  • ekspress diaqnostik sınaqlar
  • döş qəfəsinin rentgenoqramması
Full details

Treatment algorithm

INITIAL

risk qruplarında qripə yoluxma

ACUTE

böyüklər

uşaqlar

Contributors

Authors

Cristine Radojicic, MD

Staff Physician

Department of Pulmonary, Allergy and Critical Care

Cleveland Clinic

Cleveland

OH

Disclosures

CR declares that she has no competing interests.

Peer reviewers

Waleed Javaid, MD, FACP, FIDSA

Associate Professor

Medical Director of Infection Control

Infectious Disease

Department of Medicine

SUNY Upstate Medical University

Syracuse

NY

Disclosures

WJ declares that he has no competing interests.

Rachel L. Miller, MD, FAAAAI

Associate Professor of Clinical Medicine and Environmental Health Sciences

Columbia University College of Physicians and Surgeons

New York

NY

Disclosures

RLM declares that she has no competing interests.

Mark Sands, MD, FAAAAI

Chief

SUNY Buffalo School of Medicine

Division Allergy and Immunology

Buffalo

NY

Disclosures

MS declares that he has no competing interests.

An De Sutter, MD, PhD

Associate Professor

Department of General Practice and Primary Health Care

Ghent University

Ghent

Belgium

Disclosures

ADS declares that she has no competing interests.

Use of this content is subject to our disclaimer